NeuroHealth Solutions - Infectious Disease NeuroTechnologies
COVID-19 NEURO-AUGMENTED INTERVENTION THERAPY
Currently there is not a FDA approved prevention, cure or treatment for SARS-CoV2 (COVID-19) infectious disease.
What is COVID-19?
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease was first identified in the capital of China's Hubei province and has since spread globally. The World Health Organization (WHO) declared the 2019 coronavirus outbreak a Public Health Emergency of International Concern (PHEIC), and later a pandemic. How is it transmitted? The virus is mainly spread during close contact, and by small droplets produced when people cough, sneeze, or talk. These small droplets may be produced during breathing but the virus is not generally airborne. People may also catch COVID-19 by touching a contaminated surface and then their face. The virus can survive on surfaces for up to 72 hours. It is most contagious during the first three days after symptom onset, although spread may be possible before symptoms appear and in later stages of the disease. Time from exposure to onset of symptoms is generally between two and fourteen days, with an average of five days.
With public funding tied up due to politics & the fiscal year, your donations are crucial. Without donations, this solution may never be utilized & social distancing & isolation will become the new normal.
NeuroHealth Solutions (NHS) offers forward-thinking solutions for people suffering from infectious disease, traumatic brain injuries, stroke risks, stroke symptoms and other neurological disorders. Applying state-of-the-art integration of neuroscience technology, NHS has deploys proprietary systems and unique integrated medical interventions to reduce risk factors and promote recovery and rehabilitation.
NHS has taken the initiative to respond to a high level of interest in integrative strategies to augment federal public health measures to prevent COVID-19 infection. Unfortunately, no integrative measures have been validated in human trials as effective specifically for COVID-19.
NHS has developed a proactive intervention which focuses on risk identification, exposure fortification, infectious disease mitigation care management and recovery supplemental to the CDC recommendations of social distancing, hand washing, and testing under the guidance of a health care provider.
© 2020 NHS Infectious Disease Neuro Technologies © 1999-2019 Performance Research Sciences, INC © 2013-2020 Performance Research Sciences AST, LLC © 2014-2020 PRS NeuroHealth Solutions, LLC © 2019-2020 NeuroHealth Solutions, INC